Medpace (MEDP) reported Q3 earnings Monday of $3.01 per diluted share, up from $2.22 a year earlier.
Analysts polled by Capital IQ expected $2.78.
Revenue for the quarter ended Sept. 30 was $533.3 million, up from $492.5 million a year earlier.
Analysts surveyed by Capital IQ expected $541 million.
The company now expects 2024 revenue between $2.09 billion and $2.13 billion from previous guidance between $2.125 billion and $2.175 billion.
Analysts polled by Capital IQ expect $2.14 billion.
The company now expects diluted EPS between $11.71 and $12.09 from previous guidance between $11.24 and $11.93.
Analysts surveyed by Capital IQ expect $11.56.
The company's shares were falling past 10% in recent after-hours activity.
Price: 312.96, Change: -39.96, Percent Change: -11.32
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。